Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

177.67 -0.42 (-0.24%)

Streaming Delayed Price Updated: 10:48 AM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes ↗

August 10, 2022

RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday.

Via Benzinga

Masimo Clocks 85% Jump In Quarterly Sales, Provides Q3 Guidance Below Expectations ↗

August 10, 2022

Via Benzinga

Masimo Reports Second Quarter 2022 Financial Results

August 09, 2022

From Masimo

Via Business Wire

Masimo to Report Second Quarter 2022 Financial Results after Market Close on Tuesday, August 9

July 26, 2022

From Masimo

Via Business Wire

Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery

July 20, 2022

From Masimo

Via Business Wire

7 Analysts Have This to Say About Masimo ↗

May 04, 2022

Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter:

Via Benzinga

7 Best High-Growth Stocks for Young Investors ↗

July 19, 2022

The best high-growth stocks for young investors are poised to outperform once again once the markets turn positive.

Via InvestorPlace

Two-part Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Reduced Length of Hospital Stay for COVID-19 Patients

July 05, 2022

From Masimo

Via Business Wire

New Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors Determine the Severity of Asthma Attacks in Pediatric Patients

May 23, 2022

From Masimo

Via Business Wire

Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues ↗

May 04, 2022

Via Benzinga

Supply Chain Challenges To Hit Masimo's Q1 FY22 Sales ↗

March 31, 2022

Via Benzinga

Masimo's Return on Invested Capital Insights ↗

May 13, 2022

According to Benzinga Pro, during Q1, Masimo (NASDAQ:MASI) earned $46.59 million, a 31.74% increase from the preceding quarter. Masimo's sales decreased to $304.24 million, a 7.12% change since Q4.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 03, 2022

Gainers

Via Benzinga

Masimo Reports First Quarter 2022 Financial Results

May 03, 2022

From Masimo

Via Business Wire

Masimo's Earnings Outlook ↗

May 02, 2022

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an...

Via Benzinga

Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers

May 02, 2022

From Masimo

Via Business Wire

Why Jim Cramer Recommends Buying Norwegian Cruise Line ↗

March 03, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norwegian Cruise Line Holdings Ltd. (NYSE...

Via Benzinga

Masimo SedLine® Brain Function Monitoring Reduced the Use of Anesthetic Agents and Opioids in a Study on Patients Undergoing Cardiac Surgery

April 25, 2022

From Masimo

Via Business Wire

New JAMA Article Highlights the Outcome and Safety Benefits of Remote Patient Monitoring During the Pandemic and Beyond

April 18, 2022

From Masimo

Via Business Wire

Masimo Closes Acquisition of Sound United

April 12, 2022

From Masimo

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗

April 06, 2022

Upgrades

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

March 31, 2022

Goldman Sachs raised the price target on Consolidated Edison, Inc. (NYSE: ED) from $65 to $83. Consolidated Edison shares rose 0.5% to trade at $95.24 on Thursday.

Via Benzinga

The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall ↗

March 31, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Masimo Announces Certain Preliminary First Quarter 2022 Financial Results and Reaffirms Full-Year 2022 Revenue Guidance

March 30, 2022

From Masimo Corporation

Via Business Wire

New Study Finds That Noninvasive and Continuous Hemoglobin Improved Transfusion Management and Outcomes in Pediatric Patients

March 28, 2022

From Masimo

Via Business Wire

Analyst Ratings For Masimo ↗

March 17, 2022

Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings...

Via Benzinga

Masimo Debuts Telehealth for Patient SafetyNet™ at HIMSS 2022 Global Health Conference

March 14, 2022

From Masimo

Via Business Wire

Masimo's SedLine Brain Function Monitor Sensor Scores FDA Approval For Pediatric Use ↗

February 28, 2022

The FDA has FDA cleared Masimo Corp's (NASDAQ: MASI) SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG...

Via Benzinga

Masimo Announces FDA Clearance of Pediatric Indication for SedLine® Brain Function Monitoring and the SedLine Pediatric EEG Sensor

February 28, 2022

From Masimo

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022 ↗

February 18, 2022

Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago...

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.